Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Genelabs, NHRI collaborate on hepatitis C drug candidates
August 2008
SHARING OPTIONS:

REDWOOD CITY, Calif.Genelabs Technologies Inc. has entered into a collaborative research agreement with the National Health Research Institutes (NHRI) to discover and develop compounds that target the hepatitis C virus (HCV). HCV drug candidates will be developed using Genelabs' lead compounds on an existing target the chemistry and drug discovery expertise of the NHRI, a non-profit organization established by the government of the Republic of China and Genovate Biotechnology Co. Ltd., a biopharmaceutical company in Taiwan. Financial terms of the agreement were not disclosed. DDN 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.